These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment. Lombardo S; Maskos U Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383 [TBL] [Abstract][Full Text] [Related]
5. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
6. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease. Ahmed T; Zahid S; Mahboob A; Farhat SM Curr Neuropharmacol; 2017; 15(4):480-494. PubMed ID: 27012953 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Auld DS; Kornecook TJ; Bastianetto S; Quirion R Prog Neurobiol; 2002 Oct; 68(3):209-45. PubMed ID: 12450488 [TBL] [Abstract][Full Text] [Related]
8. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Hampel H; Mesulam MM; Cuello AC; Farlow MR; Giacobini E; Grossberg GT; Khachaturian AS; Vergallo A; Cavedo E; Snyder PJ; Khachaturian ZS Brain; 2018 Jul; 141(7):1917-1933. PubMed ID: 29850777 [TBL] [Abstract][Full Text] [Related]
10. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766 [TBL] [Abstract][Full Text] [Related]
11. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both? Hernandez CM; Dineley KT Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028 [TBL] [Abstract][Full Text] [Related]
12. A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders. Bertrand D; Wallace TL Curr Top Behav Neurosci; 2020; 45():1-28. PubMed ID: 32451956 [TBL] [Abstract][Full Text] [Related]
13. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Pákáski M; Kálmán J Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955 [TBL] [Abstract][Full Text] [Related]
14. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology. Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517 [TBL] [Abstract][Full Text] [Related]